PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
| العنوان: | PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY |
|---|---|
| المؤلفون: | M. Pereira, G. Marques, A.-B. Sarmento-Ribeiro |
| المصدر: | HemaSphere. 6:1717-1718 |
| بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Hematology |
| تدمد: | 2572-9241 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::4efc60e478f51379d485e65b269985f6 https://doi.org/10.1097/01.hs9.0000850200.50801.a5 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi...........4efc60e478f51379d485e65b269985f6 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 25729241 |
|---|